Ep 55 - COVID19 Vaccines for Children Aged 5-12: What Parents Need to Know - a podcast by London Ctr for Policy Research

"On 29 October 2021, the Food and Drug Association (FDA) extended its Emergency Authorization for the Pfizer-BioNTech “vaccine” to be given to reduce serious COVID-19 infections in children aged 5 to 11 years. The FDA provided little evidence for their decision except for a minimal sized "immunobridging" study which incorrectly considered blood antibody levels to be the same thing as immunity to the COVID-19 virus. It is not. Especially when using a mRNA “vaccine” that is demonstrably no longer working in the older age groups." - Dr. Steve Hatfill from his sourced researched paper: "Referenced Data for Parent’s Concerning the Pfizer COVID-19 Vaccination for Children Aged 5-12"

Dr. Steve Hatfill, MD, Virologist and Senior Fellow at the London Center for Policy Research, discusses the research in his well-sourced document with LCPR President LTC (Ret) Tony Shaffer as parents need to be aware of not only the government-touted benefits of the FDA-Approved COVID vaccine from Pfizer but the potential risks they may also pose to some young children.

See Dr. Hatfill's full research paper here: https://www.londoncenter.org/COVID-Data-Children

Thank you for watching; please feel free to comment, share and subscribe.

Or, please feel free to make a contribution here: paypal.com/us/fundraiser/charity/1338653

Thought to Action is presented by the London Center for Policy Research https://www.londoncenter.org​

Further episodes of Thought to Action

Further podcasts by London Ctr for Policy Research

Website of London Ctr for Policy Research